|
|
Session 32-Themed Discussion
Themed Discussion: Animal and Human Studies of PrEP and Vaginal Rings
Wednesday, 1-2 pm; Room 6E |
1086
 |
Intermittent Oral PrEP with Truvada Prevents Vaginal SHIV Transmission in Macaques
Jessica Radzio, W Aung, S Ruone, A Martin, C-P Pau, E Sweeney, J Mitchell, S Bachman, W Heneine, and G Garcia-Lerma
CDC, Atlanta, GA, US |
1087
|
T Cell Chemo-vaccination after Vaginal SHIV Exposure and Oral or Topical PrEP
Ellen Kersh, K Butler, W Luo, P Srinivasan, J Radzio, S Sharma, J Smith, C Dobard, G Garcia-Lerma, and J McNicholl
CDC, Atlanta, GA, US |
1088
|
Intravaginal Ring Delivery of the Pyrimidinedione IQP-0528 Results in Protective Concentrations in Vaginal Biopsies of Pigtailed Macaques, Novel Models to Assess Pharmacokinetics/Pharmacodynamics
Pedro Mesquita1, R Rastogi2, T Johnson2, P Srinivasan3, J Smith3, R Buckheit III4, P Kiser2, and B Herold1
1Albert Einstein Coll of Med, Bronx, NY, US; 2Univ of Utah, Salt Lake City, US; 3CDC, Atlanta, GA, US; and 4ImQuest BioSci, Frederick, MD, US |
1089
|
Safety, Acceptability, and Adherence of Monthly Dapiravine Vaginal Microbicide Rings for HIV Prevention
Annalene Nel1, M Kamupira1, C Woodsong1, E Montgomery2, and J Nuttall1
1Intl Partnership for Microbicides, Silver Spring, MD, US and 2RTI Intl, San Francisco, CA, US |
|
|
